Genomma Lab Internacional, S.A.B. de C.V.
GNMLFOTCHealthcare● Active
$0.95
$-0.13(-12.04%)
Market Cap$928865018
P/E Ratio—
52W High$1.17
52W Low$0.91
Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · GNMLF · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $17.52B | $18.61B | $16.78B | $16.91B | $15.47B |
| Cost of Revenue | $6.51B | $6.68B | $6.51B | $6.69B | $5.92B |
| Gross Profit | $11.01B | $11.93B | $10.27B | $10.22B | $9.56B |
| Gross Margin %(computed) | 62.84% | 64.12% | 61.22% | 60.43% | 61.75% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.00B | $8.06B | $118.38B | $135.74B | $134.82B |
| Total Operating Expenses | $7.28B | $8.03B | $7.01B | $6.90B | $6.56B |
| Operating Income | $3.73B | $3.91B | $3.27B | $3.32B | $2.99B |
| Operating Margin %(computed) | 21.26% | 20.99% | 19.49% | 19.64% | 19.35% |
| Interest Income | $0.11B | $0.11B | $2.72B | $0.12B | $0.07B |
| Interest Expense | $1.05B | $0.89B | $14.37B | $0.53B | $0.44B |
| Income Before Tax | $2.43B | $0.14B | $29.79B | $2.25B | $27.75B |
| Income Tax Expense | $0.83B | $0.04B | $11.00B | $0.87B | $0.91B |
| Net Income | $1.61B | $1.49B | $1.11B | $1.40B | $1.31B |
| Net Margin %(computed) | 9.16% | 8.02% | 6.59% | 8.26% | 8.44% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $1.65 | $1.53 | $1.15 | $1.41 | $1.30 |
| Wtd Avg Shares | 0.97B | 0.98B | 0.96B | 0.99B | 1.01B |
| EBITDA | $4.10B | $4.14B | $2.89B | $3.00B | $2.92B |
| EBITDA Margin %(computed) | 23.43% | 22.24% | 17.23% | 17.76% | 18.90% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · MXN · B
Explore more Genomma Lab Internacional, S.A.B. de C.V. data
About Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) Income Statement
Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, GNMLF reported revenue of $17.52B, gross profit of $11.01B (gross margin 62.84%), and net income of $1.61B — a net profit margin of 9.16%.
Frequently asked questions
GNMLF · 4 questionsGenomma Lab Internacional, S.A.B. de C.V. (GNMLF) reported revenue of $17.52B for 2025, down 5.8% year-over-year.
GNMLF revenueGNMLF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08